Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?Zacks Investment Research • 01/13/26
Day One Biopharmaceuticals, Inc. (DAWN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue GuidanceGlobeNewsWire • 01/11/26
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual MeetingGlobeNewsWire • 11/24/25
Day One to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/18/25
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to TradeZacks Investment Research • 11/17/25
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening DiseasesGlobeNewsWire • 11/13/25
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual MeetingGlobeNewsWire • 11/10/25
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/04/25
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?Zacks Investment Research • 10/30/25
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025GlobeNewsWire • 10/21/25
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a BetZacks Investment Research • 10/14/25
Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last?Zacks Investment Research • 10/06/25
Day One Biopharmaceuticals: Bear Case Priced In, But Bull Case Is Not (Rating Upgrade)Seeking Alpha • 08/08/25
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to TradeZacks Investment Research • 07/24/25
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025GlobeNewsWire • 07/22/25